BMRA: Prakiraan volume dodolan Biomerica, Inc

Logo korporat perusahaan Biomerica, Inc. (BMRA)

Risks for Biomerica, Inc. (BMRA) are linked to a dependence on partner networks and M&A transactions. The estimated sales volume of the firm, as displayed by the GURU.Markets platform, has stabilized at 0.00, confirming volatility. Stability is provided by the contract manufacturing of test systems, external IT solutions for transmitting diagnoses, and the outsourcing of logistics to third-party services, while high-tech analysis remains an internal asset of the company.

Volume dodolan sing dikarepake perusahaan: Biomerica, Inc. (BMRA) kanggo 04.07.2022 - 18.11.2026

Ringkesan rincian data analitis Biomerica Inc (BMRA)

- kuotasi lan prakiraan analis:
Pambiji fundamental:Biomerica Inc.
Produk merek Biomerica, Inc

Biomerica, Inc. is scaling access to early gastrointestinal cancer diagnostics through pharmacy chains. This sales benchmark for the company reflects the implementation dynamics of non-invasive tests. The metric measures the operational return on commercial strategies, converting market demand into projected revenue volume. Growth in the line confirms distribution efficiency, while a decline signals product stagnation. Trend analysis allows for an assessment of the risk of capital freeze in current projects.

Pesaing utama

Prakiraan pendapatan perusahaan Agilent (A)|Prakiraan volume dodolan Quest Diagnostics Incorporated (DGX)|Prakiraan pendapatan perusahaan Illumina Corp ILMN|EXAS: Prakiraan pendapatan perusahaan|RVTY: Volume dodolan mangsa ngarep perusahaan|Prakiraan dodolan perusahaan bio-rad.com (BIO)|NNNN: Prakiraan volume dodolan|Sotera Health - Pendapatan mangsa ngarep perusahaan|QDEL (quidel.com) - Prakiraan volume dodolan|OPK: Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan CDNA (CareDx)|Prakiraan volume dodolan Maravai LifeSciences (MRVI)|Fulgent Genetics, Inc. - Volume dodolan mangsa ngarep perusahaan|LAB: Prakiraan pendapatan perusahaan|Cytek Corp - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan OSUR (OraSure Technologies)|XGN: Prakiraan volume dodolan|MDxHealth - Pendapatan mangsa ngarep perusahaan|LUCD (luciddx.com) - Prakiraan volume dodolan|PRE - Prakiraan dodolan perusahaan|Prakiraan pendapatan perusahaan Insight Molecular Diagnostics Inc (IMDX)|TRIB - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan PRPH (ProPhase Labs, Inc.)|Dodolan mangsa ngarep perusahaan ainos.com (AIMD)|Co-Diagnostics Inc - Prakiraan volume dodolan|HSCS - Prakiraan volume dodolan|Cardio Diagnostics (CDIO) - Prakiraan pendapatan perusahaan|ONCO - Dodolan mangsa ngarep perusahaan|VRAX (Virax Biolabs Corp) - Prakiraan volume dodolan|Bluejay Diagnostics, Inc. (BJDX) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan AWH|Accelerate Diagnostics Inc. - Prakiraan pendapatan perusahaan|Centogene - Volume dodolan mangsa ngarep perusahaan|Enzo Biochem, Inc. (ENZ) - Volume dodolan sing dikarepake perusahaan|Prakiraan volume pendapatan perusahaan Fresh2 Group Limited FRES|Dodolan mangsa ngarep perusahaan gtglabs.com GENE|23andMe Holding Co (ME) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan PMD